Product: Ceftriaxone for Injection, USP 250 mg per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-094-02
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20230515
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated